3,809 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Bought by Oddo BHF Asset Management Sas

Oddo BHF Asset Management Sas purchased a new position in Axon Enterprise, Inc. (NASDAQ:AXON) during the third quarter, HoldingsChannel.com reports. The fund purchased 3,809 shares of the biotechnology company’s stock, valued at approximately $1,522,000.

A number of other hedge funds have also recently modified their holdings of AXON. Wealth Enhancement Advisory Services LLC increased its holdings in Axon Enterprise by 21.7% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 9,153 shares of the biotechnology company’s stock valued at $2,693,000 after purchasing an additional 1,634 shares during the period. Envestnet Portfolio Solutions Inc. raised its holdings in shares of Axon Enterprise by 18.0% during the second quarter. Envestnet Portfolio Solutions Inc. now owns 5,272 shares of the biotechnology company’s stock valued at $1,551,000 after acquiring an additional 804 shares in the last quarter. Swedbank AB raised its holdings in shares of Axon Enterprise by 2.2% during the second quarter. Swedbank AB now owns 130,397 shares of the biotechnology company’s stock valued at $38,368,000 after acquiring an additional 2,800 shares in the last quarter. Blue Trust Inc. lifted its stake in Axon Enterprise by 987.5% in the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after acquiring an additional 79 shares during the period. Finally, Vaughan Nelson Investment Management L.P. boosted its holdings in Axon Enterprise by 53.2% in the second quarter. Vaughan Nelson Investment Management L.P. now owns 157,094 shares of the biotechnology company’s stock valued at $46,223,000 after acquiring an additional 54,526 shares in the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling

In other Axon Enterprise news, Director Julie A. Cullivan sold 1,261 shares of Axon Enterprise stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total value of $860,077.66. Following the completion of the sale, the director now owns 2,392 shares of the company’s stock, valued at approximately $1,631,487.52. This trade represents a 34.52 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Michael Garnreiter sold 1,000 shares of the stock in a transaction on Monday, September 16th. The shares were sold at an average price of $380.99, for a total value of $380,990.00. Following the sale, the director now directly owns 27,259 shares in the company, valued at $10,385,406.41. This trade represents a 3.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 99,590 shares of company stock worth $49,176,907 in the last quarter. Corporate insiders own 6.10% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently commented on AXON. Needham & Company LLC raised their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Robert W. Baird raised their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. The Goldman Sachs Group lifted their price objective on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. JMP Securities increased their target price on Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research report on Thursday, October 31st. Finally, Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. One equities research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus price target of $488.67.

Axon Enterprise Trading Up 1.3 %

NASDAQ AXON opened at $644.91 on Friday. Axon Enterprise, Inc. has a 12 month low of $241.72 and a 12 month high of $698.67. The stock has a market cap of $49.17 billion, a P/E ratio of 166.64, a P/E/G ratio of 14.14 and a beta of 1.01. The stock’s fifty day moving average price is $539.52 and its 200-day moving average price is $404.63. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.